Tavger

Company Overview

Snapshot

Founded in August 2009 by Michael Tavger, Tavger operates with 1–10 employees. The company focuses on developing and manufacturing medical aesthetics devices, including products like Affinity GJS and MesostripS, which are currently released.

Business overview

Tavger specializes in bioengineering solutions for skin quality improvement, developing and manufacturing medical devices for various applications. Its technology enables deep 3D chemical peeling by delivering AHA acids into the dermis without affecting the skin surface, allowing for year-round procedures without pigmentation concerns. The company's product portfolio includes devices for preventing surgical infection, treating chronic wounds in outpatient and nursing care settings, and home wound care, serving the healthcare and life sciences sectors, particularly in dermatology and medical aesthetics.

Company Intelligence Q&A

Who founded Tavger?

Tavger was founded by Michael Tavger, who serves as the Co-founder & CEO.

When was Tavger founded?

Tavger was founded in August 2009.

What is Tavger's primary focus?

Tavger designs and manufactures devices for various medical applications, including the prevention and mitigation of surgical infection sites, chronic wound treatment, and medical aesthetics.

What is Tavger's core technology in medical aesthetics?

Tavger's core technology allows for deep 3D chemical peeling by delivering relatively weak AHA acids to the dermis, which can be adjusted for depth and material amount. This process avoids surface damage, enabling procedures in any season without concerns about pigmentation.

What products has Tavger released?

Tavger has released several products, including Affinity GJS, BioRef, Affinity, MesostripS, and MesoStripD.